Ingrid Wencker

Ingrid Wencker is a seasoned professional in the pharmaceutical and healthcare industries, currently serving as the Marketing & Market Access Director at Merz Therapeutics since March 2022. With extensive experience at Norgine since 2010 in various roles, including Market Access, Public Affairs, and Global Market Access Manager, Ingrid has developed pricing strategies, value propositions, and public affairs strategies for a diverse product portfolio in therapeutic areas such as oncology and gastroenterology. Previous positions include Marketing Manager at Bristol-Myers Squibb and Nycomed, where Ingrid successfully led product strategies and managed significant product launches. Educational qualifications include a Master's degree in Medical Economic Evaluation and Market Access from Université Paris Dauphine and a business degree from ESCP Business School, along with a background in biochemical engineering and life sciences.